Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche

FE Lock, PC McDonald, Y Lou, I Serrano, SC Chafe, C Ostlund, S Aparicio, JY Winum, CLAUDIU TRANDAFIR Supuran, S Dedhar
2013-10-01
Abstract:The sub-population of tumor cells termed ‘cancer stem cells’(CSCs) possess the capability to generate tumors, undergo epithelial–mesenchymal transition (EMT) and are implicated in metastasis, making treatments to specifically target CSCs an attractive therapeutic strategy. Tumor hypoxia plays a key role in regulating EMT and cancer stem cell function. Carbonic anhydrase IX (CAIX) is a hypoxia-inducible protein that regulates cellular pH to promote cancer cell survival and invasion in hypoxic microenvironments and is a biomarker of poor prognosis for breast cancer metastasis and survival. Here, we demonstrate that inhibition of CAIX expression or activity with novel small-molecule inhibitors in breast cancer cell lines, or in primary metastatic breast cancer cells, results in the inhibition of breast CSC expansion in hypoxia. We identify the mTORC1 axis as a critical pathway downstream of CAIX in the regulation of …
What problem does this paper attempt to address?